$CIRX

CIRTRAN CORP

CIK:0000813716|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 1,171,666	$ 168,435	$ 2,333,019	$ 629,251
Cost of sales	552,642	83,493	1,250,613	274,015
Gross profit	619,024	84,942	1,082,406	355,236
Operating expenses
Employee costs	128,567	122,546	258,587	251,454
Selling, general and administrative expenses	329,829	155,654	627,069	340,313
Total operating expenses	458,396	278,200	885,656	591,767
Income (loss) from operations	160,628	(193,258)	196,750	(236,531)
Other income (expense)
Interest expense	(214,734)	(203,387)	(426,540)	(405,761)
Gain on forgiveness of debt			5,511	5,141
Gain (loss) on derivative valuation	(41,411)	(127,850)	63,025	4,384
Other income		6		6
Total other expense	(256,145)	(331,231)	(358,004)	(396,230)
Net loss from continuing operations	(95,517)	(524,489)	(161,254)	(632,761)
Income (loss) from discontinued operations	(12,407)	(38,261)	2,274,031	(76,102)
Net income (loss) before income tax	(107,924)	(562,750)	2,112,777	(708,863)
Income tax				(9,323)
Net income (loss)	$ (107,924)	$ (562,750)	$ 2,112,777	$ (718,186)
Net loss from continuing operations per common share, basic	$ (0.02)	$ (0.11)	$ (0.03)	$ (0.13)
Net loss from continuing operations per common share, diluted	(0.02)	(0.11)	(0.03)	(0.13)
Net income (loss) from discontinued operations per common share, basic	(0.00)	(0.01)	0.46	(0.02)
Net income (loss) from discontinued operations per common share, diluted	(0.00)	(0.01)	0.46	(0.02)
NNet income (loss) per common share, basic	(0.02)	(0.12)	0.43	(0.14)
Net income (loss) per common share, diluted	$ (0.02)	$ (0.12)	$ 0.43	$ (0.14)
Basic weighted average common shares outstanding	4,945,417	4,945,417	4,945,417	4,945,417
Diluted weighted average common shares outstanding	4,945,417	4,945,417	4,945,417	4,945,417

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2026	Mar. 31, 2026	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Cash flows from operating activities
Net income (loss)	$ (107,924)	$ 2,220,701	$ (562,750)	$ (155,436)	$ 2,112,777	$ (718,186)
Adjustments to reconcile net income (loss) to net cash used by operating activities:
(Income) loss from discontinued operations					(2,274,031)	76,102
Depreciation expense					1,142	987
Gain on derivative valuation	41,411		127,850		(63,025)	(4,384)	$ 64,891
Debt discount amortization					54,551	51,965
Gain on forgiveness of debt					(5,511)	(5,141)
Changes in operating assets and liabilities:
Inventory					104,376	(99,242)
Deposits on inventory					73,078	3,264
Deposits on inventory - related party					(62)	637
Accounts receivable					(114,457)	8,933
Other current assets					(5,023)	(19,751)
Accounts payable					(16,567)	9,623
Liabilities for product returns and credits					(39,259)	15,330
Accrued liabilities					(118,037)	(396,662)
Accrued payroll and compensation					110,641	144,482
Accrued interest					309,461	304,955
Short-term advances payable					(5,468)
Net cash provided (used) by operating activities					124,586	(627,088)
Cash flows from financing activities:
Bank overdraft						(30,384)
Proceeds from related-party loans					23,962	661,807
Net cash provided by financing activities					23,962	631,423
Net change in cash					148,548	4,335
Cash, beginning of period		$ 9,589			9,589
Cash, end of period	$ 158,137		$ 4,335		158,137	4,335	$ 9,589
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash	$ 158,137	$ 9,589
Inventory	1,032,170	1,136,546
Accounts receivable, net	480,118	365,661
Other current assets	473,363	468,340
Total current assets	2,352,060	2,261,424
Investment in securities at cost	248,000	248,000
Property and equipment, net of accumulated depreciation	3,465	4,607
Total assets	2,603,525	2,514,031
Current liabilities:
Accounts payable	127,370	149,448
Liabilities for product returns and credits	51,551	90,810
Accrued liabilities	2,640,845	2,758,884
Accrued payroll and compensation expense	5,784,805	5,674,164
Accrued interest, current portion	7,048,884	6,739,423
Convertible debenture, current portion, net of discounts	264,284	264,284
Derivative liabilities	2,330,519	2,393,544
Liabilities from discontinued operations	2,544,396	4,818,427
Total current liabilities:	22,616,546	24,694,382
Note payable, net of current portion	643,000	643,000
Convertible debenture, net of current portion, net of discount	2,338,397	2,283,844
Total liabilities	25,597,943	27,621,226
Commitments and contingencies
Stockholders’ deficit:
Common stock, par value $0.001; 100,000,000 shares authorized; 4,945,417 shares issued and outstanding	4,945	4,945
Additional paid-in capital	37,233,561	37,233,561
Accumulated deficit	(60,232,924)	(62,345,701)
Total stockholders’ deficit	(22,994,418)	(25,107,195)
Total liabilities and stockholders’ deficit	2,603,525	2,514,031
Nonrelated Party [Member]
Current assets:
Deposits on inventory	208,210	281,288
Current liabilities:
Short-term advances payable	157,398	162,866
Note payable	90,000	90,000
Related Party [Member]
Current assets:
Deposits on inventory	62
Current liabilities:
Short-term advances payable	1,424,661	1,400,699
Note payable	$ 151,833	$ 151,833